Data-driven strategy consulting and proprietary analytics for pharmaceutical and biotech senior leaders focused on oncology and specialty therapeutics. Commercial and market-access strategy, custom integrated launch and channel plans across cell & gene therapy, immunology, neurology, rare diseases, and precision medicine.